EMA Authorised: Truvelog Mix 30 (insulin aspart) — Sanofi Winthrop Industrie

View source ↗

Summary

EMA has authorized Truvelog Mix 30 (insulin aspart) for the treatment of diabetes mellitus in the European Union.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Truvelog Mix 30 (insulin aspart)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Sanofi Winthrop Industrie. Decision date: 06/07/2023